The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. (Q43566270)
Jump to navigation
Jump to search
scientific article published in March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. |
scientific article published in March 2001 |
Statements
The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells (English)
Cartee L
Wang Z
Decker RH
Chellappan SP
Fusaro G
Hirsch KG
Sankala HM
Dent P